Report Detail

Pharma & Healthcare Global Ophthalmic Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4586308
  • |
  • 09 April, 2024
  • |
  • Global
  • |
  • 108 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Ophthalmic Biologics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the Ophthalmic Biologics industry chain, the market status of Age-related Macular Degeneration Treatment (Ranibizumab, Bevacizumab), Diabetic Retinopathy Treatment (Ranibizumab, Bevacizumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Ophthalmic Biologics.
Regionally, the report analyzes the Ophthalmic Biologics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Ophthalmic Biologics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Ophthalmic Biologics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Ophthalmic Biologics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ranibizumab, Bevacizumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Ophthalmic Biologics market.
Regional Analysis: The report involves examining the Ophthalmic Biologics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Ophthalmic Biologics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Ophthalmic Biologics:
Company Analysis: Report covers individual Ophthalmic Biologics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Ophthalmic Biologics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Age-related Macular Degeneration Treatment, Diabetic Retinopathy Treatment).
Technology Analysis: Report covers specific technologies relevant to Ophthalmic Biologics. It assesses the current state, advancements, and potential future developments in Ophthalmic Biologics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Ophthalmic Biologics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Ophthalmic Biologics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ranibizumab
Bevacizumab
Aflibercept
Brolucizumab
Faricimab
Others
Market segment by Application
Age-related Macular Degeneration Treatment
Diabetic Retinopathy Treatment
Inhibit Abnormal Angiogenesis
Major players covered
Sanofi
Novartis
Bayer
Genentech
Apellis Pharmaceuticals, Inc.
Coherus BioSciences Inc.
Iveric Bio

Regeneron
Qilu Pharmaceutical Co.,Ltd.
Chengdu Kanghong Pharmaceutical Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmic Biologics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ophthalmic Biologics, with price, sales, revenue and global market share of Ophthalmic Biologics from 2019 to 2024.
Chapter 3, the Ophthalmic Biologics competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmic Biologics breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Ophthalmic Biologics market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ophthalmic Biologics.
Chapter 14 and 15, to describe Ophthalmic Biologics sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Ophthalmic Biologics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ophthalmic Biologics Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Ranibizumab
    • 1.3.3 Bevacizumab
    • 1.3.4 Aflibercept
    • 1.3.5 Brolucizumab
    • 1.3.6 Faricimab
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ophthalmic Biologics Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Age-related Macular Degeneration Treatment
    • 1.4.3 Diabetic Retinopathy Treatment
    • 1.4.4 Inhibit Abnormal Angiogenesis
  • 1.5 Global Ophthalmic Biologics Market Size & Forecast
    • 1.5.1 Global Ophthalmic Biologics Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Ophthalmic Biologics Sales Quantity (2019-2030)
    • 1.5.3 Global Ophthalmic Biologics Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Ophthalmic Biologics Product and Services
    • 2.1.4 Sanofi Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Novartis
    • 2.2.1 Novartis Details
    • 2.2.2 Novartis Major Business
    • 2.2.3 Novartis Ophthalmic Biologics Product and Services
    • 2.2.4 Novartis Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novartis Recent Developments/Updates
  • 2.3 Bayer
    • 2.3.1 Bayer Details
    • 2.3.2 Bayer Major Business
    • 2.3.3 Bayer Ophthalmic Biologics Product and Services
    • 2.3.4 Bayer Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bayer Recent Developments/Updates
  • 2.4 Genentech
    • 2.4.1 Genentech Details
    • 2.4.2 Genentech Major Business
    • 2.4.3 Genentech Ophthalmic Biologics Product and Services
    • 2.4.4 Genentech Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Genentech Recent Developments/Updates
  • 2.5 Apellis Pharmaceuticals, Inc.
    • 2.5.1 Apellis Pharmaceuticals, Inc. Details
    • 2.5.2 Apellis Pharmaceuticals, Inc. Major Business
    • 2.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
    • 2.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.6 Coherus BioSciences Inc.
    • 2.6.1 Coherus BioSciences Inc. Details
    • 2.6.2 Coherus BioSciences Inc. Major Business
    • 2.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
    • 2.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Coherus BioSciences Inc. Recent Developments/Updates
  • 2.7 Iveric Bio
  • 2.7.1 Iveric Bio

Details

  • 2.7.2 Iveric Bio

Major Business

  • 2.7.3 Iveric Bio

Ophthalmic Biologics Product and Services

  • 2.7.4 Iveric Bio

Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)

  • 2.7.5 Iveric Bio

Recent Developments/Updates

  • 2.8 Regeneron
    • 2.8.1 Regeneron Details
    • 2.8.2 Regeneron Major Business
    • 2.8.3 Regeneron Ophthalmic Biologics Product and Services
    • 2.8.4 Regeneron Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Regeneron Recent Developments/Updates
  • 2.9 Qilu Pharmaceutical Co.,Ltd.
    • 2.9.1 Qilu Pharmaceutical Co.,Ltd. Details
    • 2.9.2 Qilu Pharmaceutical Co.,Ltd. Major Business
    • 2.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
    • 2.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.10 Chengdu Kanghong Pharmaceutical Group
    • 2.10.1 Chengdu Kanghong Pharmaceutical Group Details
    • 2.10.2 Chengdu Kanghong Pharmaceutical Group Major Business
    • 2.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
    • 2.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates

3 Competitive Environment: Ophthalmic Biologics by Manufacturer

  • 3.1 Global Ophthalmic Biologics Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Ophthalmic Biologics Revenue by Manufacturer (2019-2024)
  • 3.3 Global Ophthalmic Biologics Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Ophthalmic Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Ophthalmic Biologics Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Ophthalmic Biologics Manufacturer Market Share in 2023
  • 3.5 Ophthalmic Biologics Market: Overall Company Footprint Analysis
    • 3.5.1 Ophthalmic Biologics Market: Region Footprint
    • 3.5.2 Ophthalmic Biologics Market: Company Product Type Footprint
    • 3.5.3 Ophthalmic Biologics Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ophthalmic Biologics Market Size by Region
    • 4.1.1 Global Ophthalmic Biologics Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Ophthalmic Biologics Consumption Value by Region (2019-2030)
    • 4.1.3 Global Ophthalmic Biologics Average Price by Region (2019-2030)
  • 4.2 North America Ophthalmic Biologics Consumption Value (2019-2030)
  • 4.3 Europe Ophthalmic Biologics Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Ophthalmic Biologics Consumption Value (2019-2030)
  • 4.5 South America Ophthalmic Biologics Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Ophthalmic Biologics Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Ophthalmic Biologics Sales Quantity by Type (2019-2030)
  • 5.2 Global Ophthalmic Biologics Consumption Value by Type (2019-2030)
  • 5.3 Global Ophthalmic Biologics Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Ophthalmic Biologics Sales Quantity by Application (2019-2030)
  • 6.2 Global Ophthalmic Biologics Consumption Value by Application (2019-2030)
  • 6.3 Global Ophthalmic Biologics Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Ophthalmic Biologics Sales Quantity by Type (2019-2030)
  • 7.2 North America Ophthalmic Biologics Sales Quantity by Application (2019-2030)
  • 7.3 North America Ophthalmic Biologics Market Size by Country
    • 7.3.1 North America Ophthalmic Biologics Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Ophthalmic Biologics Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Ophthalmic Biologics Sales Quantity by Type (2019-2030)
  • 8.2 Europe Ophthalmic Biologics Sales Quantity by Application (2019-2030)
  • 8.3 Europe Ophthalmic Biologics Market Size by Country
    • 8.3.1 Europe Ophthalmic Biologics Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Ophthalmic Biologics Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Ophthalmic Biologics Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Ophthalmic Biologics Market Size by Region
    • 9.3.1 Asia-Pacific Ophthalmic Biologics Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Ophthalmic Biologics Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Ophthalmic Biologics Sales Quantity by Type (2019-2030)
  • 10.2 South America Ophthalmic Biologics Sales Quantity by Application (2019-2030)
  • 10.3 South America Ophthalmic Biologics Market Size by Country
    • 10.3.1 South America Ophthalmic Biologics Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Ophthalmic Biologics Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Ophthalmic Biologics Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Ophthalmic Biologics Market Size by Country
    • 11.3.1 Middle East & Africa Ophthalmic Biologics Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Ophthalmic Biologics Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Ophthalmic Biologics Market Drivers
  • 12.2 Ophthalmic Biologics Market Restraints
  • 12.3 Ophthalmic Biologics Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ophthalmic Biologics and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ophthalmic Biologics
  • 13.3 Ophthalmic Biologics Production Process
  • 13.4 Ophthalmic Biologics Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ophthalmic Biologics Typical Distributors
  • 14.3 Ophthalmic Biologics Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Ophthalmic Biologics. Industry analysis & Market Report on Ophthalmic Biologics is a syndicated market report, published as Global Ophthalmic Biologics Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Ophthalmic Biologics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,731.80
    4,097.70
    5,463.60
    3,208.56
    4,812.84
    6,417.12
    546,325.20
    819,487.80
    1,092,650.40
    289,222.80
    433,834.20
    578,445.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report